Brokerages Set CVS Health Corporation (NYSE:CVS) PT at $91.67

Shares of CVS Health Corporation (NYSE:CVS) have been given an average recommendation of “Moderate Buy” by the twenty-six ratings firms that are covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation, twenty have issued a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $94.6667.

CVS has been the subject of a number of analyst reports. Sanford C. Bernstein lifted their price target on shares of CVS Health from $86.00 to $87.00 and gave the company a “market perform” rating in a research report on Friday. Piper Sandler reiterated an “overweight” rating and set a $101.00 target price (up previously from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Leerink Partners upped their target price on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. Royal Bank Of Canada reissued an “outperform” rating on shares of CVS Health in a research report on Thursday, December 4th. Finally, Zacks Research lowered shares of CVS Health from a “strong-buy” rating to a “hold” rating in a report on Monday, September 8th.

Hedge Funds Weigh In On CVS Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Cantor Fitzgerald Investment Advisors L.P. lifted its position in shares of CVS Health by 1.6% during the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after buying an additional 6,615 shares during the period. Brandywine Global Investment Management LLC increased its holdings in shares of CVS Health by 20.1% in the first quarter. Brandywine Global Investment Management LLC now owns 3,421,519 shares of the pharmacy operator’s stock worth $231,808,000 after acquiring an additional 572,533 shares in the last quarter. Holderness Investments Co. acquired a new stake in CVS Health during the 1st quarter worth approximately $300,000. Red Mountain Financial LLC bought a new stake in shares of CVS Health during the second quarter worth $293,000. Finally, AE Wealth Management LLC boosted its stake in CVS Health by 607.5% in the 2nd quarter. AE Wealth Management LLC now owns 242,221 shares of the pharmacy operator’s stock worth $16,708,000 after purchasing an additional 207,984 shares during the period. 80.66% of the stock is owned by institutional investors.

CVS Health Price Performance

NYSE:CVS opened at $77.42 on Wednesday. The stock has a market cap of $98.28 billion, a P/E ratio of 203.64, a PEG ratio of 0.79 and a beta of 0.48. CVS Health has a one year low of $43.56 and a one year high of $85.15. The company has a fifty day moving average price of $79.05 and a 200 day moving average price of $72.20. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company’s revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the business posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Analysts anticipate that CVS Health will post 5.89 earnings per share for the current year.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.